Xinqiao Hospital Of Chongqing
Clinical trials sponsored by Xinqiao Hospital Of Chongqing, explained in plain language.
-
MRNA cancer therapy takes on blood tumors
Disease control Recruiting nowThis early-phase trial is testing an experimental mRNA-based drug that turns the body's own cells into cancer fighters. The drug targets CD19, a protein found on certain blood cancer cells. Researchers will enroll 47 adults with B-cell lymphoma or leukemia who have run out of sta…
Phase: EARLY_PHASE1 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for Late-Stroke patients: drug before procedure may boost recovery
Disease control Recruiting nowThis study tests whether giving a clot-busting drug (rhTNK-tPA) before a clot-removal procedure helps stroke patients who arrive 4.5 to 24 hours after symptoms start. About 820 adults with a blocked large artery in the brain will receive either the drug or a placebo. The goal is …
Phase: PHASE3 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Stroke showdown: which Pre-Clot drug wins?
Disease control Recruiting nowThis study tests two different medicines given before a procedure to remove a blood clot from the brain in people having a major stroke. The goal is to see which medicine helps more people recover with little or no disability. About 800 adults who arrive at the hospital within 24…
Phase: PHASE2, PHASE3 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could a simple CT scan be enough to decide stroke treatment?
Knowledge-focused Recruiting nowThis study tests whether a simple CT scan (NCCT) works as well as advanced imaging (CTP/MRI) for choosing stroke patients who need emergency clot removal. About 1,846 adults with acute stroke arriving within 24 hours of symptoms will be enrolled. The goal is to see if the simpler…
Phase: NA • Sponsor: Xinqiao Hospital of Chongqing • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC